ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• A Better Approach To eConsent: Flexibility With Enabled Technology

  Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.

• Why eSource: The Advantages of Abandoning Paper Records

  Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.

• A New Take On The Evolving Role Of AI In Clinical Trials

  Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.

• CRO Uses CRIO eSource To Double Monitoring Productivity

  Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.

• Building A Clinical Research AI Governance Framework

  Learn how structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust while enabling innovation in increasingly data-driven trials.

• Improving Clinical Trial Performance Through Central eSource

  See how a top five pharmaceutical company leveraged our esource platform to enhance site performance, improve data consistency, and enable remote monitoring.

• How A Dedicated Medical Affairs Team Drives Site Engagement

  See how improvements made to SIP have allowed for quick access to study documents and bulk actions for streamlined document management and enhanced user experience.

• Simplifying The Data Journey From EHR To EDC

  Explore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.

• Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations

  Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind. 

• Different Stakeholder Perspectives On Navigating DHT Guidance

  In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.